Cuprina gets FDA clearance for first Lucilia cuprina maggot therapy
Tweet Send to a Friend
Cuprina Holdings (NASDAQ: CUPR) received U.S. Food and Drug Administration 510(k) clearance for MEDIFLY Maggots, a medical-grade Lucilia cuprina larvae ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


